clinical research

Addiction and Pharmacology Research

Open Trials  |  Trials Coming Soon  |  Current Projects


Open Trials


Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
Principal Investigator:
Gantt Galloway, PharmD

Contact:
Jennifer Siegrist
415-641-3370
Email
Phase II Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence
Visit this study on ClinicalTrials.gov.
Males and Females ages 18-65 that use methamphetamine and want to quit. Must be able to come in 3x per week for visits.Open
Principal Investigator:
Keith Flower, MD

Contact:
Jayme Mulkey
415 641 3370
Email
A Pilot Trial of Naltrexone for Methamphetamine Addiction - Role of the A118G SNP
Visit this study on ClinicalTrials.gov.
Males and Females ages 18-50 that use methamphetamine and want to quitOpen
Principal Investigator:
Linghui Li MD PhD &
John Mendelson MD

Contact:
Linghui Li
415-641-3370
Email
An Open-Label Study to Evaluate the Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine in Healthy AdultsHealthy males and females ages 18-55 Open


Back to top


Trials Coming Soon

Principal Investigator/Contact Information Protocol Title Patient Population Recruitment Period
Principal Investigator:
Gantt Galloway, PharmD

Contact:
Margie Jang, NP
415-641-3370
Email
A Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Lofexidine
Cocaine-experienced males and females aged 18-50 years. Must be able to be inpatient 10 nights and 11 daysComing Soon
Principal Investigator:
Gantt P. Galloway PharmD

Contact:
Jose Guillen
415 641 3370
Email
A Dose Ranging Study of Modafinil for Methamphetamine DependenceMales and Females ages 18-50 that use methamphetamine and want to quitComing Soon
Principal Investigator:
John Mendelson MD

Contact:
Jennifer Siegrist
415-641-3370
Email
The Effects of MDMA on Sleep Architecture, Water Homeostasis and Cognitive Function: Acute and 24-48 hour Post Dose Discontinuation Effects MDMA-experienced males and females aged 18-50 yearsComing Soon


updated: 11/09/09
Back to top


Current Projects

APRL Current Projects


Back to top